Tomasz Szymanski

Head of Heath Economics


Tomasz is a former consultant at the World Health Organization where he focused on noncommunicable diseases (NCD), related tools and a UN Global Pulse project in partnership with Microsoft on the value of big data in retrieving evidence for policy making in NCD.

His previous experience also includes leading a team at the Government Agency for Health Technology Assessment (HTA) in Poland. He is due to graduate from Imperial College London with a PhD in Health Economics and his research focuses on medicine optimisation, primarily on cost-effectiveness analysis and the wider economic impact of medication review.

He has created two de novo cost-effectiveness models for medication review and examined the impact of complex healthcare interventions on economic evaluations.